Characterization of the stage in natural killer cell development in 14.5-day mouse fetal liver using adult bone marrow stroma

Experimental Hematology

Volumn 27, Issue 6, 1999, Pages 1046-1056

  Lu, Jing ^a   Patrene, Kenneth D ^a   Appasamy, Pierette M ^a   Herberman, Ronald B ^a   Boggs, Sallie S ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow stroma Natural killer cells; Cytokines; Murine fetal liver; NK cell differentiation; NK cell progenitors

Indexed keywords

CYTOKINE; FLT3 LIGAND; INTERLEUKIN 15; RECOMBINANT INTERLEUKIN 2; RECOMBINANT STEM CELL FACTOR;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; FETUS; FETUS LIVER; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; STEM CELL; STROMA CELL;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL DIVISION; CULTURE MEDIA, CONDITIONED; FLOW CYTOMETRY; GESTATIONAL AGE; INTERLEUKIN-15; INTERLEUKIN-2; KILLER CELLS, NATURAL; LIVER; MICE; MICE, INBRED C57BL; STEM CELL FACTOR; STEM CELLS; STROMAL CELLS;

EID: 0033065651     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00042-9     Document Type: Article

References (48)

1. Seaman W.E., Merigan T.C., Talal N. Natural killing in estrogen-treated mice responds poorly to poly I.C despite normal stimulation of circulating interferon. J Immunol. 123:1979;2903.
2. Seaman W.E., Gindhart T.D., Greenspan J.S., Blackman M.A., Talal N. Natural killer cells, bone, and the bone marrow. studies in estrogen-treated mice and in congenitally osteopetrotic (mi/mi) mice J Immunol. 122:1979;2541.
3. Hackett J. Jr., Tutt M., Lipscomb M., Bennett M., Koo G., Kumar V. Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells. J Immunol. 136:1986;3124.
4. Kumar V., Ben-Ezra J., Bennett M., Sonnenfeld G. Natural killer cells in mice treated with 89strontium. normal target-binding cell numbers but inability to kill even after interferon administration J Immunol. 123:1979;1832.
5. van den Brink M.R., Boggs S.S., Herberman R.B., Hiserodt J.C. The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures. J Exp Med. 172:1990;303.
6. Vecchini F., Delfino D., Patrene K.D., DeLeo A., Lu L., Herberman R.B., Boggs S.S. Generation of natural killer cells from long-term cultures of mouse bone marrow. Nat Immun. 12:1993;1.
7. Delfino D.V., Patrene K.D., DeLeo A.B., DeLeo R., Herberman R.B., Boggs S.S. Role of CD44 in the development of natural killer cells from precursors in long-term cultures of mouse bone marrow. J Immunol. 152:1994;5171.
8. Delfino D.V., Patrene K.D., Lu J., Deleo A., Deleo R., Herberman R.B., Boggs S.S. Natural killer cell precursors in the CD44neg/dim T-cell receptor population of mouse bone marrow. Blood. 87:1996;2394.
9. Rebel V.I., Miller C.L., Thornbury G.R., Dragowska W.H., Eaves C.J., Lansdorp P.M. A comparison of long-term repopulating hematopoietic stem cells in fetal liver and adult bone marrow from the mouse. Expe Hematol. 24:1996;638.
10. Jordan C.T., McKearn J.P., Lemischka I.R. Cellular and developmental properties of fetal hematopoietic stem cells. Cell. 61:1990;953.
11. Jordan C.T., Lemischka I.R. Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev. 4:1990;220.
12. McKearn J.P., McCubrey J., Fagg B. Enrichment of hematopoietic precursor cells and cloning of multipotential B-lymphocyte precursors. Proc Natl Acad Sci U S A. 82:1985;7414.
13. Harrison D.E. Long-term erythropoietic repopulating ability of old, young, and fetal stem cells. J Exp Med. 157:1983;1496.
14. Forrester L.M., Bernstein A., Rossant J., Nagy A. Long-term reconstitution of the mouse hematopoietic system by embryonic stem cell-derived fetal liver. Proc Natl Acad Sci U S A. 88:1991;7514.
15. Bell S.E., Zamoyska R. Identification of thymocyte precursors in murine fetal liver. Europ J Immunol. 21:1991;2931.
16. Aiba Y., Ogawa M. Development of natural killer cells, B lymphocytes, macrophages, and mast cells from hematopoietic progenitors in culture of murine liver cells. Blood. 90:1997;3923.
17. Morrison S.J., Hemmati H.D., Wandycz A.M., Weissman I.L. The purification and characterization of fetal liver hematopoietic stem cells. Proc Natl Acad Sci U S A. 92:1995;10302.
18. Poggi A., Sargiacomo M., Biassoni R., Pella N., Sivori S., Revello V., Costa P., Valtieri M., Russo G., Mingari M.C.et al. Extrathymic differentiation of T lymphocytes and natural killer cells from human embryonic liver precursors. Proc Natl Acad Sci U S A. 90:1993;4465.
19. Sanchez M.J., Muench M.O., Roncarolo M.G., Lanier L.L., Phillips J.H. Identification of a common T/natural killer cell progenitor in human fetal thymus. J Exp Med. 180:1994;569.
20. Sanchez M.J., Spits H., Lanier L.L., Phillips J.H. Human natural killer cell committed thymocytes and their relation to the T cell lineage. J Exp Med. 178:1993;1857.
21. Phillips J.H., Hori T., Nagler A., Bhat N., Spits H., Lanier L.L. Ontogeny of human natural killer (NK) cells. fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon, delta proteins J Exp Med. 175:1992;1055.
22. Hori T., Phillips J.H., Duncan B., Lanier L.L., Spits H. Human fetal liver-derived CD7+CD2lowCD3-CD56- clones that express CD3 gamma, delta, and epsilon and proliferate in response to interleukin-2 (IL-2), IL-3, IL-4, or IL-7. implications for the relationship between T and natural killer cells Blood. 80:1992;1270.
23. Manaseki S., Searle R.F. Natural killer (NK) cell activity of first trimester human decidua. Cell Immunol. 121:1989;166.
24. Phan D.T., Mihalik R., Benczur M., Domotori J., Kiss C., Petranyi G.G., Hollan S.R. Expression of NK-cell associated antigen on human fetal liver cells. Thymus. 11:1988;253.
25. Thilaganathan B., Nicolaides K.H., Morgan G. Subpopulations of CD34-positive haemopoietic progenitors in fetal blood. Br J Haematol. 87:1994;634.
26. Thilaganathan B., Abbas A., Nicolaides K.H. Fetal blood natural killer cells in human pregnancy. Fetal Diag Ther. 8:1993;149.
27. Moingeon P., Rodewald H.R., McConkey D., Mildonian A., Awad K., Reinherz E.L. Generation of natural killer cells from both Fc gamma RII/III+ and Fc gamma RII/III- murine fetal liver progenitors. Blood. 82:1993;1453.
28. Brooks C.G., Georgiou A., Jordan R.K. The majority of immature fetal thymocytes can be induced to proliferate to IL-2 and differentiate into cells indistinguishable from mature natural killer cells. J Immunol. 151:1993;6645.
29. Garni-Wagner B.A., Witte P.L., Tutt M.M., Kuziel W.A., Tucker P.W., Bennett M., Kumar V. Natural killer cells in the thymus. Studies in mice with severe combined immune deficiency. J Immunol. 144:1990;796.
30. Dorshkind K., Pollack S.B., Bosma M.J., Phillips R.A. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (SCID). J Immunol. 134:1985;3798.
31. Kundig T.M., Schorle H., Bachmann M.F., Hengartner H., Zinkernagel R.M., Horak I. Immune responses in interleukin-2-deficient mice. Science. 262:1993;1059.
32. Aiba Y., Hirayama F., Ogawa M. Clonal proliferation and cytokine requirement of murine progenitors for natural killer cells. Blood. 89:1997;4005.
33. Moore K.A., Ema H., Lemischka I.R. In vitro maintenance of highly purified, transplantable hematopoietic stem cells. Blood. 89:1997;4337.
34. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. III. Validity tests for the single-hit Poisson model. J Immunol Meth. 72:1984;29.
35. Dunn T.B., Poter M. A transplantable mast cell neoplasm in the mouse. J Natl Cancer Inst. 18:1957;587.
36. 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus. J Natl Cancer Inst. 53:1974;1103.
37. Spangrude G.J., Klein J., Heimfeld S., Aihara Y., Weissman I.L. Two monoclonal antibodies identify thymic-repopulating cells in mouse bone marrow. J Immunol. 142:1989;425.
38. Hyman R., Lesley J., Schulte R., Trotter J. Progenitor cells in the thymus. most thymus-homing progenitor cells in the adult mouse thymus bear Pgp-1 glycoprotein but not interleukin-2 receptor on their cell surface Cellular Immunology. 101:1986;320.
39. Lesley J., Trowbridge I.S. Genetic characterization of a polymorphic murine cell-surface glycoprotein. Immunogenetics. 15:1982;313.
40. Lesley J., Schulte R., Hyman R. Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. Exper Cell Res. 187:1990;224.
41. Lesley J., Hyman R., Kincade P.W. CD44 and its interaction with extracellular matrix. Advan Immunol. 54:1993;271.
42. Puzanov I.J., Bennett M., Kumar V. IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J Immunol. 157:1996;4282.
43. Puzanov I.J., Williams N.S., Schatzle J., Sivakumar P.V., Bennett M., Kumar V. Ontogeny of NK cells and the bone marrow microenvironment. where does IL15 fit in? Res Immunol. 148:1997;195.
44. Ballas Z.K., Rasmussen W. Lymphokine-activated killer cells. VII. IL-4 induces an NK1.1+CD8 alpha+beta- TCR-alpha beta B220+ lymphokine-activated killer subset. J Immunol. 150:1993;17.
45. Coffman B. Surface antigen expression and immunoglobin rearrangement during mouse pre-B cell development. Immunol Rev. 69:1982;5.
46. Asensi V., Kimeno K., Kawamura I., Sakumoto M., Nomoto K. Treatment of autoimmune MRL/lpr mice with anti-B220 monoclonal antibody reduces the level of anti-DNA antibodies and lymphadenopathies. Immunology. 68:1989;204.
47. Osawa M., Hanada K., Hamada H., Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 273:1996;242.
48. Mrozek E., Anderson P., Caligiuri M.A. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood. 87:1996;2632.